BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25455654)

  • 21. Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).
    Hackanson B; Rückert A; Lübbert M
    Eur J Haematol; 2009 Dec; 83(6):611-2. PubMed ID: 19682063
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia.
    Dvorak P; Hruba M; Subrt I
    Leuk Res; 2009 Jun; 33(6):860-1. PubMed ID: 18977531
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia.
    Pieroni F; Oliveira FM; Panepucci RA; Voltarelli JC; Simões BP; Falcão RP
    Bone Marrow Transplant; 2006 Apr; 37(8):801-2. PubMed ID: 16501585
    [No Abstract]   [Full Text] [Related]  

  • 24. [Difference in the expression of TRAIL mRNA between acute and chronic myeloid leukemia patients and its significance].
    Zhang WH; Zhang Y; Ma BG
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):166-8. PubMed ID: 23611229
    [No Abstract]   [Full Text] [Related]  

  • 25. D104N polymorphism in endostatin, an angiogenesis inhibitor, in acute and chronic myeloid leukaemia.
    Nascimento H; Lourenço GJ; Ortega MM; Yamaguti GG; Costa FF; Lima CS
    Leuk Res; 2007 Aug; 31(8):1158-9. PubMed ID: 17067672
    [No Abstract]   [Full Text] [Related]  

  • 26. Association of KIR2DS4 and its variant KIR1D with leukemia.
    Giebel S; Nowak I; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Kyrcz-Krzemien S; Kusnierczyk P
    Leukemia; 2008 Nov; 22(11):2129-30; discussion 2130-1. PubMed ID: 18463675
    [No Abstract]   [Full Text] [Related]  

  • 27. Rare translocations involving chromosome band 8p11 in myeloid neoplasms.
    Lee SG; Park TS; Lee ST; Lee KA; Song J; Kim J; Suh B; Choi JR; Park R
    Cancer Genet Cytogenet; 2008 Oct; 186(2):127-9. PubMed ID: 18940479
    [No Abstract]   [Full Text] [Related]  

  • 28. MicroRNAs in myeloid malignancies.
    Gordon JE; Wong JJ; Rasko JE
    Br J Haematol; 2013 Jul; 162(2):162-76. PubMed ID: 23679825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late appearance of a Philadelphia translocation with minor-BCR/ABL transcript in a t(7;11)(p15;p15) acute myeloid leukemia.
    Shimamoto T; Ohyashiki K; Ohyashiki JH; Fujimura T; Kodama A; Miyazawa K; Aizawa S; Toyama K
    Leukemia; 1995 Apr; 9(4):640-2. PubMed ID: 7723398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and phenotypic analysis of Philadelphia chromosome-positive bilineage leukemia: possibility of a lineage switch from T-lymphoid leukemic progenitor to myeloid cells.
    Monma F; Nishii K; Ezuki S; Miyazaki T; Yamamori S; Usui E; Sugimoto Y; Lorenzo V F; Katayama N; Shiku H
    Cancer Genet Cytogenet; 2006 Jan; 164(2):118-21. PubMed ID: 16434313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Philadelphia chromosome in leukemogenesis.
    Kang ZJ; Liu YF; Xu LZ; Long ZJ; Huang D; Yang Y; Liu B; Feng JX; Pan YJ; Yan JS; Liu Q
    Chin J Cancer; 2016 May; 35():48. PubMed ID: 27233483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimal residual disease in leukaemia.
    Kumar L
    Natl Med J India; 1995; 8(4):150-3. PubMed ID: 7633307
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pathophysiology and treatment of acute myeloid leukemia].
    Naoe J
    Rinsho Ketsueki; 2003 Apr; 44(4):219-26. PubMed ID: 12784654
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML.
    Lazarevic V; Golovleva I; Nygren I; Wahlin A
    Am J Hematol; 2006 Jun; 81(6):470-1. PubMed ID: 16680752
    [No Abstract]   [Full Text] [Related]  

  • 35. Do chromosome abnormalities determine the type of acute leukemia that develops in CML?
    Bernstein R; Gale RP
    Leukemia; 1990 Jan; 4(1):65-8. PubMed ID: 2296202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukemic colony formation from patients with acute leukemia: evidence of the identity in karyotype of the colonies from patients with cytogenetic abnormalities.
    Ishibashi T
    Fukushima J Med Sci; 1987 Dec; 33(2):71-83. PubMed ID: 3509037
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
    Larsson N; Billström R; Lilljebjörn H; Lassen C; Richter J; Ekblom M; Fioretos T
    Cancer Genet Cytogenet; 2010 Jun; 199(2):89-95. PubMed ID: 20471511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells.
    Zhang JH; He YL; Zhu R; Du W; Xiao JH
    Tumour Biol; 2017 Jun; 39(6):1010428317713394. PubMed ID: 28639894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
    Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
    Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic separation of chronic myeloid leukemia stem cells from normal hematopoietic stem cells at single-cell resolution.
    Chen Y; Möbius S; Riege K; Hoffmann S; Hochhaus A; Ernst T; Rudolph KL
    Leukemia; 2023 Jul; 37(7):1561-1566. PubMed ID: 37237078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.